대장균에서 발현된 A군 로타바이러스 VP6 단백질을 이용한 로타바이러스 감염의 혈청학적 진단의 유용성
Usefulness of Escherichia coli-expressed Recombinant VP6 Proteins of Group A Rotavirus in Serodiagosis of Rotavirus Infection
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: The serologic diagnosis of rotaviral infections is not commonly used in clinical practice, but is used in seroepidemiologic studies. In this study, the usefulness of Escherichia coli-expressed recombinant VP6 proteins of group A rotavirus in the serodiagnosis of rotavirus infections by ELISA was evaluated. Methods: The recombinant VP6 proteins of group A rotavirus expressed in E. coli Rosetta II strain were purified and identified. One hundred sera from 22 children (4 healthy neonates, 13 healthy children, and 5 immunocompromised children) who had serial sera samples prior to and after rotavirus infections were provided by the Gyeongsang National University Hospital, a member of the National Biobank of Korea. IgG, IgA, and IgM antibodies against rVP6 were analyzed by ELISA in all of the patients and Western blot analysis in 4 neonates. Results: ELISA tests using rVP6 proteins of group A rotavirus as antigen revealed that IgG, IgA, and IgM antibodies increased after rotaviral infections in most neonates and healthy children. IgG antibodies also increased after rotaviral infections in most immunocompromised children without an adequate increase in IgM or IgA antibodies. Western blot analysis in four neonates revealed very early IgM antibody responses, even in the sera with low optical densities in ELISA tests. Conclusion: Our study showed that ELISA using rVP6 as an antigen is a valid diagnostic tool for seroepidemiologic studies of rotavirus infections and Western blot analysis is a sensitive test in detecting IgG, IgA, and and IgM antibodies in patients with rotavirus infections. (Korean J Pediatr Gastroenterol Nutr 2010; 13: 134∼145)
Abstract
Purpose: The serologic diagnosis of rotaviral infections is not commonly used in clinical practice, but is used in seroepidemiologic studies. In this study, the usefulness of Escherichia coli-expressed recombinant VP6 proteins of group A rotavirus in the serodiagnosis of rotavirus infections by ELISA was evaluated. Methods: The recombinant VP6 proteins of group A rotavirus expressed in E. coli Rosetta II strain were purified and identified. One hundred sera from 22 children (4 healthy neonates, 13 healthy children, and 5 immunocompromised children) who had serial sera samples prior to and after rotavirus infections were provided by the Gyeongsang National University Hospital, a member of the National Biobank of Korea. IgG, IgA, and IgM antibodies against rVP6 were analyzed by ELISA in all of the patients and Western blot analysis in 4 neonates. Results: ELISA tests using rVP6 proteins of group A rotavirus as antigen revealed that IgG, IgA, and IgM antibodies increased after rotaviral infections in most neonates and healthy children. IgG antibodies also increased after rotaviral infections in most immunocompromised children without an adequate increase in IgM or IgA antibodies. Western blot analysis in four neonates revealed very early IgM antibody responses, even in the sera with low optical densities in ELISA tests. Conclusion: Our study showed that ELISA using rVP6 as an antigen is a valid diagnostic tool for seroepidemiologic studies of rotavirus infections and Western blot analysis is a sensitive test in detecting IgG, IgA, and and IgM antibodies in patients with rotavirus infections. (Korean J Pediatr Gastroenterol Nutr 2010; 13: 134∼145)
참고문헌 (21)
- Chung JY, "Acute viral gastroenteritis: recent trends and updates", Korean J Pediatr Gastroenterol Nutr, 10, pp.53~57 (2007)
- Kapikian AZ, "Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance", J Infect Dis, 147, pp.95~106 (1983)
- Bishop RF, "Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children", N Engl J Med, 309, pp.72~76 (1983)
- Bhan MK, "Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea", J Infect Dis, 168, pp.282~287 (1993)
- 박신이, "신생아에서 로타바이러스 위장관염의 임상양상에 대한 고찰", Korean Journal of Pediatrics, 48(10), pp.1121~1125 (2005), 대한소아과학회
- 서현주, "로타바이러스 감염이 관련된 신생아 괴사성 장염", Korean Journal of Pediatrics, 52(1), pp.56~60 (2009), 대한소아과학회
- 황필주, "노로바이러스에 의한 급성 위장관염의 임상양상 : 로타바이러스 장염과의 비교", Korean Journal of Pediatrics, 52(4), pp.453~457 (2009), 대한소아과학회
- Iijima Y, "An outbreak of rotavirus infection among adults in an institution for rehabilitation: long-term residence in a closed community as a risk factor for rotavirus illness", Scand J Infect Dis, 38, pp.490~496 (2006)
- 강기수, "제주지역 로타바이러스 위장관염 환아로부터 분리한 A군 로타바이러스의 VP7 Genotypes에 대한 연구", 대한소아소화기영양학회지, 9(2), pp.147~152 (2006), 대한소아소화기영양학회
- Ramani S, "Investigation of the environment and of mothers in transmission of rotavirus infections in the neonatal nursery", J Med Virol, 80, pp.1099~1105 (2008)
- Kim DS, "Immunogenicity and safety of a pentavalent human- bovine (WC3) reassortant rotavirus vaccine in healthy infants in Korea", Pediatr Infect Dis J, 27, pp.177~178 (2008)
- Brüssow H, "Prevalence of antibodies to rotavirus in different age-groups of infants in Bochum, West Germany", J Infect Dis, 157, pp.1014~1022 (1988)
- Ward RL, "VP6: A candidate rotavirus vaccine", J Infect Dis, 202, pp.S101~107 (2010)
- Bishop RF, "Estimation of rotavirus immunoglobulin G antibodies in human serum samples by enzyme-linked immunosorbent assay: expression of results as units derived from a standard curve", J Clin Microbiol, 19, pp.447~452 (1984)
- Xu J, "Serum antibody responses in children with rotavirus diarrhea can serve as proxy for protection", Clin Diagn Lab Immunol, 12, pp.273~279 (2005)
- Mukhopadhya I, "Anti-VP6 IgG antibodies against group A and group C rotaviruses in South India", Epidemiol Infect, 138, pp.442~447 (2010)
- Hjelt K, "Protective effect of preexisting rotavirus- specific immunoglobulin A against naturally acquired rotavirus infection in children", J Med Virol, 21, pp.39~47 (1987)
- Velázquez FR, "Serum antibody as a marker of protection against natural rotavirus infection and disease", J Infect Dis, 182, pp.1602~1609 (2000)
- Clemens JD, "Seroepidemiologic evaluation of antibodies to rotavirus as correlates of the risk of clinically significant rotavirus diarrhea in rural Bangladesh", J Infect Dis, 165, pp.161~165 (1992)
- O'Ryan ML, "Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections", J Infect Dis, 169, pp.504~511 (1994)
- Hjelt K, "Intestinal and serum immune response to a naturally acquired rotavirus gastroenteritis in children", J Pediatr Gastroenterol Nutr, 44, pp.60~66 (1985)